129 related articles for article (PubMed ID: 15855670)
1. Hormonal regulation of circulating C-reactive protein in men.
Kovacs A; Henriksson P; Hamsten A; Wallén H; Björkegren J; Tornvall P
Clin Chem; 2005 May; 51(5):911-3. PubMed ID: 15855670
[No Abstract] [Full Text] [Related]
2. Bone mineral density in patients with prostatic cancer treated with orchidectomy and with estrogens.
Eriksson S; Eriksson A; Stege R; Carlström K
Calcif Tissue Int; 1995 Aug; 57(2):97-9. PubMed ID: 7584882
[TBL] [Abstract][Full Text] [Related]
3. Adrenocortical function in prostatic cancer patients: effects of orchidectomy or different modes of estrogen treatment on basal steroid levels and on the response to exogenous adrenocorticotropic hormone.
Carlström K; Stege R
Urol Int; 1990; 45(3):160-3. PubMed ID: 2161578
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular and all-cause mortality in prostatic cancer patients treated with estrogens or orchiectomy as compared to the standard population.
Aro J
Prostate; 1991; 18(2):131-7. PubMed ID: 2006119
[TBL] [Abstract][Full Text] [Related]
5. [Hormone therapy in carcinoma of the prostate].
Marberger H
Wien Klin Wochenschr; 1966 Jul; 78(29):512-4 passim. PubMed ID: 5992834
[No Abstract] [Full Text] [Related]
6. Urethral obstruction secondary to carcinoma of prostate: response to endocrine treatment.
Varenhorst E; Alund G
Urology; 1985 Apr; 25(4):354-6. PubMed ID: 3157256
[TBL] [Abstract][Full Text] [Related]
7. Treatment of prostatic carcinoma with polyestradiol phosphate combined with ethinylestradiol.
Jönsson G
Scand J Urol Nephrol; 1971; 5(2):97-102. PubMed ID: 5093112
[No Abstract] [Full Text] [Related]
8. Comparison of primary orchiectomy with oestrogen therapy in advanced prostatic cancer. A 2-year follow-up report of a national, prospective prostatic cancer study.
Haapiainen R; Rannikko S; Alfthan O
Br J Urol; 1986 Oct; 58(5):528-33. PubMed ID: 3779355
[TBL] [Abstract][Full Text] [Related]
9. [Surgical and hormonal therapy of prostatic carcinoma].
Frick J
Wien Med Wochenschr; 1977 Aug; 127(15):480-2. PubMed ID: 906541
[No Abstract] [Full Text] [Related]
10. Orchiectomy versus oestrogen in the treatment of advanced prostatic cancer.
Haapiainen R; Rannikko S; Ruutu M; Ala-Opas M; Hansson E; Juusela H; Permi J; Saarialho M; Viitanen J; Alfthan O
Br J Urol; 1991 Feb; 67(2):184-7. PubMed ID: 2004233
[TBL] [Abstract][Full Text] [Related]
11. Deteriorated arterial supply to the lower limb during oral oestrogen therapy of patients with prostatic carcinoma.
Henriksson P; Linde B
Urol Int; 1994; 53(2):74-8. PubMed ID: 7801420
[TBL] [Abstract][Full Text] [Related]
12. Orchiectomy, estrogen therapy and radiotherapy in locally advanced (T3-4 M0) prostatic cancer.
Aro J; Haapiainen R; Kajanti M; Rannikko S; Alfthan O
Scand J Urol Nephrol Suppl; 1988; 110():103-7. PubMed ID: 3187397
[TBL] [Abstract][Full Text] [Related]
13. The oestrogenic effects of ethinyl oestradiol/polyoestradiol phosphate and estramustine phosphate in patients with prostatic carcinoma. A comparative study of oestrogen sensitive liver proteins, gonadotrophins and prolactin.
Daehlin L; Damber JE; von Schoultz B; Bergman B
Br J Urol; 1986 Aug; 58(4):412-6. PubMed ID: 3092893
[TBL] [Abstract][Full Text] [Related]
14. Pretreatment hormone levels in prostatic cancer.
Haapiainen R; Rannikko S; Alfthan O; Adlercreutz H
Scand J Urol Nephrol Suppl; 1988; 110():137-43. PubMed ID: 3187401
[TBL] [Abstract][Full Text] [Related]
15. Comparison of endocrine and radiation therapy in locally advanced prostatic cancer.
Aro J; Haapiainen R; Kajanti M; Rannikko S; Alfthan O
Eur Urol; 1988; 15(3-4):182-6. PubMed ID: 3063541
[TBL] [Abstract][Full Text] [Related]
16. [Hormonal therapy of prostatic carcinoma].
Martz G
Internist (Berl); 1968 Sep; 9(9):375-80. PubMed ID: 4918657
[No Abstract] [Full Text] [Related]
17. Patients at high risk of cardiovascular complications in oestrogen treatment of prostatic cancer.
Henriksson P; Edhag O; Eriksson A; Johansson SE
Br J Urol; 1989 Feb; 63(2):186-90. PubMed ID: 2649197
[TBL] [Abstract][Full Text] [Related]
18. [Back up contraception].
Dacheva T
Akush Ginekol (Sofiia); 2008; 47 Suppl 2():28-31. PubMed ID: 19504704
[No Abstract] [Full Text] [Related]
19. The administration of estrogens, combined with anti-androgens, has beneficial effects on the hormonal features and asymmetric dimethyl-arginine levels, in women with the polycystic ovary syndrome.
Charitidou C; Farmakiotis D; Zournatzi V; Pidonia I; Pegiou T; Karamanis N; Hatzistilianou M; Katsikis I; Panidis D
Atherosclerosis; 2008 Feb; 196(2):958-65. PubMed ID: 17418849
[TBL] [Abstract][Full Text] [Related]
20. Immediate estrogen or estramustine phosphate therapy versus deferred endocrine treatment in nonmetastatic prostate cancer: a randomized multicenter study with 15 years of followup. The South Sweden Prostate Cancer Study Group.
Lundgren R; Nordle O; Josefsson K
J Urol; 1995 May; 153(5):1580-6. PubMed ID: 7714978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
